Strategic Acquisition LiteCure was acquired by DJO Global in December 2020, indicating a strong channel for distribution and integration into a larger medical technology portfolio. This presents an opportunity to align sales messaging with DJO’s broader customer base and leverage enhanced sales and service resources.

Diverse Market Presence With three divisions serving human and veterinary medicine and customers ranging from clinics to professional sports and horse racing, LiteCure has a broad, multi-segment footprint ripe for cross-selling light therapy devices, consumables, and maintenance programs across veterinary and human healthcare markets.

Growth Potential Revenue is in the low-to-mid single digits with a small to mid-sized employee base, suggesting room for scalable sales expansion, partner programs, and training-led adoption to accelerate penetration in new clinics, clinics’ athletic departments, and equine/multi-species facilities.

Education as Driver Historical emphasis on educating users about photobiomodulation therapy indicates a receptive audience for performance-focused case studies, webinars, and certification-driven onboarding to drive repeat purchases and premium device deployment.

Digital & Ecom Readiness Existing tech stack including WordPress, Shopify, WooCommerce, and Pardot shows readiness for digital marketing, e-commerce sales, and lead nurturing campaigns to convert inquiries into LM laser purchases and service agreements.